Danny Naz

@ThePupOfWallSt

Teaching traders how to trade with conviction. Flow Education @ BullFlow https://bit.ly/4tVs0py Live Trading @ Stock Talk Insiders https://bit.ly/4dQS4fr

Science

Moderna and Merck melanoma vaccine reportedly lowered recurrence risk by 42% in trial

Intismeran autogene targets mutations unique to each patient's tumor, STAT reports.

15 Sources, 2h ago, updated 2h ago

Featured in

Moderna and Merck melanoma vaccine reportedly lowered recurrence risk by 42% in trial

Featured in

Moderna and Merck melanoma vaccine reportedly lowered recurrence risk by 42% in trial